Location: Jean Mayer Human Nutrition Research Center On Aging
Title: Diabetes remission is modulated by branched chain amino acids according to the diet consumed: From the CORDIOPREV StudyAuthor
![]() |
CARDELO, MAGDALENA - University Hospital Reina Sofia |
![]() |
ALCALA-DIAZ, JUAN - University Hospital Reina Sofia |
![]() |
GUTIERREZ-MARISCAL, FRANCISCO - University Hospital Reina Sofia |
![]() |
LOPEZ-MORENO, JAVIER - University Hospital Reina Sofia |
![]() |
VILLASANTA-GONZALEZ, ALEJANDRO - University Hospital Reina Sofia |
![]() |
ARENAS-DE LARRIVA, ANTONIO - University Hospital Reina Sofia |
![]() |
DE LA CRUZ-ARES, SILVIA - University Hospital Reina Sofia |
![]() |
DELGADO-LISTA, JAVIER - University Hospital Reina Sofia |
![]() |
RODRIGUEZ-CANTALEJO, FERNANDO - University Hospital Reina Sofia |
![]() |
LUQUE, RAUL - Maimonides Biomedical Research Institute Of Cordoba (IMIBIC) |
![]() |
ORDOVAS, JOSE - Jean Mayer Human Nutrition Research Center On Aging At Tufts University |
![]() |
PEREZ-MARTINEZ, PABLO - University Hospital Reina Sofia |
![]() |
CAMARGO, ANTONIO - University Hospital Reina Sofia |
![]() |
LOPEZ-MIRANDA, JOSE - University Hospital Reina Sofia |
Submitted to: Molecular Nutrition and Food Research
Publication Type: Peer Reviewed Journal Publication Acceptance Date: 11/24/2021 Publication Date: 1/7/2022 Citation: Cardelo, M.P., Alcala-Diaz, J.F., Gutierrez-Mariscal, F.M., Lopez-Moreno, J., Villasanta-Gonzalez, A., Arenas-De Larriva, A., De La Cruz-Ares, S., Delgado-Lista, J., Rodriguez-Cantalejo, F., Luque, R.M., Ordovas, J., Perez-Martinez, P., Camargo, A., Lopez-Miranda, J. 2022. Diabetes remission is modulated by branched chain amino acids according to the diet consumed: From the CORDIOPREV Study. Molecular Nutrition and Food Research. https://doi.org/10.1002/mnfr.202100652. DOI: https://doi.org/10.1002/mnfr.202100652 Interpretive Summary: Blood levels of a specific type of amino acid known as Branched Chain Amino Acids (BCAA) have been previously associated with type 2 diabetes mellitus (T2DM). Investigators at the HNRCA in Boston, in collaboration with Spanish investigators, aimed to investigate whether their levels could be predictors of T2DM remission following the consumption of a Mediterranean diet (Med) or a low-fat (LF) diet. The analyses of these BCAAs in the CORDIOPREV study suggest that their measurement could potentially be used to select the most suitable diet to induce T2DM remission by nutritional strategies in cardiovascular patients. Technical Abstract: SCOPE: Branched Chain Amino Acids (BCAA) plasma levels may be differentially associated with type 2 diabetes mellitus (T2DM) remission through the consumption of the Mediterranean diet (Med) and a low-fat (LF) diet. METHODS: One hundred eighty-three newly diagnosed T2DM patients within the CORDIOPREV study are randomized to consume the Med or a LF diet. BCAA plasma levels (isoleucine, leucine, and valine) are measured at fasting and after 120 min of an oral glucose tolerance test (OGTT) at the baseline of the study and after 5 years of the dietary intervention. RESULTS: Isoleucine, leucine, and valine plasma levels after 120 min of an OGTT in the Med diet (N = 80) are associated by COX analysis with T2DM remission: HR per SD (95% CI): 0.53 (0.37-0.77), 0.75 (0.52-1.08), and 0.61 (0.45-0.82), respectively; no association is found in patients who consumed a LF diet (N = 103). BCAA plasma levels combined in a score show a HR of 3.33 (1.55-7.19) of T2DM remission for patients with a high score values in the Med diet, while in those with a LF diet, no association is found. CONCLUSION: The study suggests that BCAA measurements potentially be used as a tool to select the most suitable diet to induce T2DM remission by nutritional strategies. |